TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
HeraMED Ltd. ( (AU:HMD) ) has issued an update.
HeraMED Limited has announced a new commercial agreement with Telcare Medical Supply LLC, a subsidiary of Royal Philips, to deliver a comprehensive digital maternity care solution in the U.S. This collaboration combines Philips’ monitoring devices and infrastructure with HeraMED’s HeraCARE platform, providing a scalable remote patient monitoring ecosystem for U.S. hospitals and health systems. The initiative aims to enhance maternity care by integrating device data, clinical dashboards, and educational content, thereby supporting mothers and clinicians throughout the maternity journey. The agreement marks a significant step for HeraMED in expanding its market presence and offering innovative solutions to improve maternity care.
More about HeraMED Ltd.
HeraMED Limited is an innovative medical data and technology company focused on transforming maternity care through digital solutions. The company offers a hybrid maternity care platform that integrates hardware and software, including its in-home fetal and maternal heart rate monitor, HeraBEAT. HeraMED’s proprietary platform, HeraCARE, aims to enhance prenatal and postpartum care by leveraging cloud computing, artificial intelligence, and big data to improve patient engagement, support healthcare professionals, and enable early risk detection.
YTD Price Performance: 85.00%
Average Trading Volume: 1,595,181
Technical Sentiment Signal: Buy
Current Market Cap: A$38.56M
Learn more about HMD stock on TipRanks’ Stock Analysis page.